Total Payments
$91,866
2024 Payments
$19,398
Companies
38
Transactions
591
Medicare Patients
2,344
Medicare Billing
$393,153
Payment Breakdown by Category
Consulting$85,400 (93.0%)
Food & Beverage$6,406 (7.0%)
Education$60.35 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $85,400 | 180 | 93.0% |
| Food and Beverage | $6,406 | 404 | 7.0% |
| Education | $60.35 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $48,000 | 118 | $0 (2022) |
| CSL Plasma Inc. | $37,400 | 62 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,430 | 66 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $562.79 | 32 | $0 (2022) |
| GlaxoSmithKline, LLC. | $449.67 | 26 | $0 (2024) |
| Amgen Inc. | $354.49 | 23 | $0 (2024) |
| Novo Nordisk Inc | $334.50 | 20 | $0 (2024) |
| ABBVIE INC. | $291.55 | 17 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $286.84 | 37 | $0 (2018) |
| Lilly USA, LLC | $282.48 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,398 | 67 | CSL Plasma Inc. ($18,700) |
| 2023 | $19,256 | 59 | CSL Plasma Inc. ($18,700) |
| 2022 | $14,586 | 67 | CSL Behring ($13,950) |
| 2021 | $11,677 | 54 | CSL Behring ($11,300) |
| 2020 | $11,343 | 41 | CSL Behring ($11,100) |
| 2019 | $11,381 | 48 | CSL Behring ($10,900) |
| 2018 | $2,197 | 105 | CSL Behring ($750.00) |
| 2017 | $2,028 | 150 | AstraZeneca Pharmaceuticals LP ($329.32) |
All Payment Transactions
591 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/11/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 11/20/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 11/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: VACCINE | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 10/09/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 09/25/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: RESPIRATORY | ||||||
| 09/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 08/07/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 560 | 1,208 | $365,709 | $102,892 |
| 2022 | 10 | 568 | 1,272 | $341,762 | $97,411 |
| 2021 | 11 | 688 | 1,478 | $398,888 | $122,064 |
| 2020 | 10 | 528 | 961 | $278,994 | $70,786 |
Total Patients
2,344
Total Services
4,919
Medicare Billing
$393,153
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 617 | $186,951 | $51,080 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 102 | 188 | $76,704 | $22,280 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 206 | $42,436 | $11,238 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $28,208 | $10,119 | 35.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 82 | 83 | $19,173 | $4,527 | 23.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 15 | $9,780 | $3,016 | 30.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 13 | 13 | $2,457 | $632.06 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 614 | $186,042 | $51,263 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 117 | 264 | $54,384 | $15,315 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 101 | $41,208 | $12,278 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $24,928 | $9,100 | 36.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 79 | 79 | $18,249 | $4,492 | 24.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 19 | $12,388 | $3,672 | 29.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 15 | $2,325 | $706.19 | 30.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,476 | $451.43 | 30.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 77 | $462.00 | $68.03 | 14.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 15 | 15 | $300.00 | $65.18 | 21.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 193 | 684 | $207,252 | $60,904 | 29.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 99 | 173 | $70,584 | $21,413 | 30.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 200 | $41,200 | $12,128 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 89 | 89 | $29,246 | $10,843 | 37.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 19 | 28 | $18,256 | $5,693 | 31.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 88 | 88 | $20,328 | $5,399 | 26.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 32 | 45 | $4,963 | $3,735 | 75.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 16 | 29 | $4,495 | $1,290 | 28.7% |
About Dr. Stephen Nelson, MD
Dr. Stephen Nelson, MD is a Family Medicine healthcare provider based in Medford, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356362008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Nelson, MD has received a total of $91,866 in payments from pharmaceutical and medical device companies, with $19,398 received in 2024. These payments were reported across 591 transactions from 38 companies. The most common payment nature is "Consulting Fee" ($85,400).
As a Medicare-enrolled provider, Nelson has provided services to 2,344 Medicare beneficiaries, totaling 4,919 services with total Medicare billing of $393,153. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Medford, OR
- Active Since 07/21/2006
- Last Updated 10/16/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356362008
Products in Payments
- FARXIGA (Drug) $1,132
- XARELTO (Drug) $413.27
- Prolia (Biological) $227.35
- TRELEGY ELLIPTA (Drug) $226.58
- VIBERZI (Drug) $213.80
- SUBOXONE SUBLINGUAL FILM (Drug) $192.71
- ELIQUIS (Drug) $171.17
- AUSTEDO (Drug) $153.43
- INVOKANA (Drug) $149.52
- TRADJENTA (Drug) $138.93
- Victoza (Drug) $127.45
- REXULTI (Drug) $106.69
- UTIBRON (Drug) $105.51
- LINZESS (Drug) $94.29
- EVENITY (Biological) $93.51
- ANORO (Drug) $89.68
- Kerendia (Drug) $89.19
- SOLIQUA (Drug) $88.08
- QULIPTA (Drug) $87.59
- LONHALA MAGNAIR (Drug) $85.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Medford
Dr. Karen Kahn, Md, MD
Family Medicine — Payments: $117,738
Family Medicine $117,738
Cindy Konecne, Do, DO
Family Medicine — Payments: $10,379
Family Medicine $10,379
Mr. Michael Ryder, D.o, D.O
Family Medicine — Payments: $8,089
Family Medicine $8,089
Dr. Thomas Marzili, M.d, M.D
Family Medicine — Payments: $6,193
Family Medicine $6,193
Dr. Timothy Wilson, Md, MD
Family Medicine — Payments: $5,551
Family Medicine $5,551
Nathaniel Fondell, M.d, M.D
Family Medicine — Payments: $4,483
Family Medicine $4,483